Home›Research›Compare›AOD-9604 vs CJC-1295 (without DAC)
Peptide ComparisonAOD-9604 vs CJC-1295 (without DAC)
Both are GH / IGF Axis peptides.
AOD-9604
Advanced Obesity Drug 9604
Half-life: 30–60 minutes
197 providers listed
CJC-1295 (without DAC)
CJC 1295
Half-life: ~30 minutes
454 providers listed
CJC-1295 (without DAC) carries stronger published evidence (RCT, 3 key studies) than AOD-9604 (Animal, 1); both are research compounds.
AOD-9604
Half-life
30–60 minutes
CJC-1295 (without DAC)
Half-life
~30 minutes
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | CJC-1295 (without DAC) |
| Oral administration option | AOD-9604 |
| More provider options (197 vs 454) | CJC-1295 (without DAC) |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
AOD-9604
CJC-1295 (without DAC)
AOD-9604
CJC-1295 (without DAC)
Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)…
Effects of [norleucine27]growth hormone-releasing hormone (GHRH) (1-29)-NH2 administration on the immune syst…
Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Imp…
About AOD-9604
AOD-9604 stimulates lipolysis and inhibits lipogenesis through mechanisms believed to be independent of the insulin-like growth factor pathway. It appears to mimic the fat-metabolising action of growth hormone without triggering the proliferative effects associated with full GH or GH-releasing peptides. Oral bioavailability has been observed in some formulations, making it of interest for non-injectable protocols.
About CJC-1295 (without DAC)
CJC-1295 without DAC (Mod GRF 1-29) is a short-acting GHRH analog that binds and activates pituitary GHRH receptors to stimulate brief, pulsatile growth hormone release. Lacking the Drug Affinity Complex, it is not albumin-bound and clears within roughly half an hour, producing discrete GH pulses rather than the sustained elevation of the DAC form.
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
AOD-9604
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
CJC-1295 (without DAC)
Class-based (investigational)
Research protocols routinely measure IGF-1 to track GH axis activity before and during use. Fasting glucose and insulin are monitored because GH elevation can reduce insulin sensitivity over time.
global — WADA
This compound falls under WADA Prohibited List category S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), prohibited at all times for competing athletes.
sourceCJC-1295 (without DAC)
Ipamorelin
Research suggests Ipamorelin and CJC-1295 may produce enhanced growth hormone release effects when combined. CJC-1295 provides sustained GHRH receptor stimulation while Ipamorelin provides pulsatile ghrelin receptor stimulation — complementary pathways studied in GH secretion research.
GLP-1 agonists
Research notes metabolic pathway overlap between growth hormone-releasing peptides and GLP-1 agonists. Both compound classes influence metabolic signaling; limited research has studied their combined effects. Consult your prescriber before combining.
AOD-9604
CJC-1295 (without DAC)
Where to source these peptides
AOD-9604
197 listed
Browse directory →
Providers offeringCJC-1295 (without DAC)
454 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More GH / IGF Axis Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated August 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). AOD-9604 vs CJC-1295 (without DAC) — Per-mg Price Comparison. Retrieved August 26, 2026, from https://peptidebase.io/peptides/compare/aod-9604/cjc-1295